Monday 10 November 2025
Home      All news      Contact us      RSS     
nytimes.com - 7 days ago

With Acquisition, Kimberly-Clark Bets That Tylenol Can Weather the Storm

The consumer products giant reached a $40 billion deal to buy Kenvue, the maker of Tylenol, despite a barrage of unproven claims from President Trump and others that use of the pain reliever during pregnancy can cause autism.


Latest News
Hashtags:   

Acquisition

 | 

Kimberly

 | 

Clark

 | 

Tylenol

 | 

Weather

 | 

Storm

 | 

Sources